Otonomy To Report Fourth Quarter And Full Year 2016 Financial Results And Provide Corporate Update Post author:Sam Post published:February 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like MeiraGTx Earns EMA PRIME Designation for Achromatopsia Gene Therapy Candidate March 1, 2018 Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017 Sanofi Falls Short of Q3 Expectations, Terminates Phase II Lung Drug From Pipeline November 1, 2017
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017